Trials / Conditions / BRAF V600E Mutation

BRAF V600E Mutation

3 registered clinical trials studyying BRAF V600E Mutation — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Trial to Evaluate CSF ctDNA and Safety of Plixorafenib Alone or With Retifanlimab in Patients With BRAF-alte NCT06610682	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	EARLY_Phase 1
Not Yet Recruiting	Evaluate the Efficacy and Safety of Aspirin in Combination With Trametinib and Dabrafenib NCT05988697	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	—
Completed	Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease NCT02281760	National Human Genome Research Institute (NHGRI)	Phase 2